Clinical trials
Terminated Nervous System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 4 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Flex Pharma, Inc. | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| Xenon Pharmaceuticals Inc. | 2 |
| Alzheimer's Disease Expert Lab (ADEL), Inc. | 1 |
| Alzheon Inc. | 1 |
| Auris Medical, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Hoffmann-La Roche | 1 |
| Hospira, now a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 28 |
| Central Nervous System Diseases | 15 |
| Brain Diseases | 12 |
| Alzheimer Disease | 9 |
| Dementia | 8 |
| Mental Disorders | 8 |
| Neurodegenerative Diseases | 8 |
| Tauopathies | 6 |
| Neurocognitive Disorders | 5 |
| Neuromuscular Diseases | 5 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.